| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0976 |
| Trial ID | ChiCTR2200057017 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CDl9 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An open clinical study on the safety and efficacy of immune cell therapy for recurrent refractory systemic lupus erythematosus |
| Year | 2022 |
| Country | China |
| Company sponsor | The General Hospital of Western Theater Command |
| Cohort 1 | |||||||
|
|||||||